Cargando…

Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer

Background: Bacillus Calmette-Guérin (BCG) immunotherapy is the standard-of-care adjuvant therapy for non-muscle-invasive bladder cancer in patients at considerable risk of disease recurrence. Although its exact mechanism of action is unknown, BCG significantly reduces this risk in responding patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kowald, Saskia, Huge, Ylva, Tandiono, Decky, Ali, Zaheer, Vazquez-Rodriguez, Gabriela, Erkstam, Anna, Fahlgren, Anna, Sherif, Amir, Cao, Yihai, Jensen, Lasse D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914090/ https://www.ncbi.nlm.nih.gov/pubmed/36766850 http://dx.doi.org/10.3390/cells12030508

Ejemplares similares

Zebrafish patient-derived xenograft models predict lymph node involvement and treatment outcome in non-small cell lung cancer
por: Ali, Zaheer, et al.
Publicado: (2022)

The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation
por: Ottosson, Kristoffer, et al.
Publicado: (2019)

Hypoxia-Induced Retinal Angiogenesis in Zebrafish as a Model to Study Retinopathy
por: Cao, Renhai, et al.
Publicado: (2008)

Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer
por: Rydell, Harriet, et al.
Publicado: (2022)

Asymptomatic renal BCG granulomatosis: An unusual complication of intravesical BCG therapy for carcinoma urinary bladder
por: Bhat, Suresh, et al.
Publicado: (2015)

BCG in Bladder Cancer Immunotherapy
por: Jiang, Song, et al.
Publicado: (2022)

Adverse events during neoadjuvant chemotherapy for muscle invasive bladder cancer—a Swedish retrospective multicentre study of a clinical database
por: Eriksson, Victoria, et al.
Publicado: (2022)

BCG treatment of human tumour xenografts in athymic nude mice.
por: Pimm, M. V., et al.
Publicado: (1978)

Laparoscopic Rectopexy with Urinary Bladder Xenograft Reinforcement
por: Mehta, Aradhana, et al.
Publicado: (2017)

Systemic BCG‐osis following intravesical BCG instillation for bladder carcinoma
por: Liaw, Frank, et al.
Publicado: (2017)

A Retrospective Analysis of the De Ritis Ratio in Muscle Invasive Bladder Cancer, with Focus on Tumor Response and Long-Term Survival in Patients Receiving Neoadjuvant Chemotherapy and in Chemo Naïve Cystectomy Patients—A Study of a Clinical Multicentre Database
por: Eriksson, Victoria, et al.
Publicado: (2022)

Invasiveness and metastasis of retinoblastoma in an orthotopic zebrafish tumor model
por: Chen, Xiaoyun, et al.
Publicado: (2015)

The Relationship between Dynamic and Static Deformation Modulus of Unbound Pavement Materials Used for Their Quality Control Methodology
por: Decký, Martin, et al.
Publicado: (2022)

Bladder Cancer Immunotherapy: BCG and Beyond
por: Askeland, Eric J., et al.
Publicado: (2012)

The Risk of Thromboembolism in Patients with Muscle Invasive Bladder Cancer before and after Cystectomy Depending on Blood Group and Neoadjuvant Chemotherapy—A Multicentre Retrospective Cohort Study
por: Schulz Hägersten, Emma, et al.
Publicado: (2023)

BCG Induced Necrosis of the Entire Bladder Urothelium
por: Krönig, Malte, et al.
Publicado: (2015)

Recognition and Treatment of BCG Failure in Bladder Cancer
por: Lightfoot, Andrew J., et al.
Publicado: (2011)

The use of intravesical BCG in urothelial carcinoma of the bladder
por: Alhunaidi, Omar, et al.
Publicado: (2019)

Autophagy Controls BCG-Induced Trained Immunity and the Response to Intravesical BCG Therapy for Bladder Cancer
por: Buffen, Kathrin, et al.
Publicado: (2014)

Clinical outcomes and survival differences between primary, secondary and concomitants carcinoma in situ of urinary bladder treated with BCG immunotherapy
por: Piszczek, Radosław, et al.
Publicado: (2020)

Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy
por: Alvaeus, Julia, et al.
Publicado: (2019)

Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer
por: Lukacs, S., et al.
Publicado: (2013)

The Anti-Tumoral Potential of Phosphonate Analog of Sulforaphane in Zebrafish Xenograft Model
por: Rudzinska-Radecka, Magdalena, et al.
Publicado: (2021)

Disseminated BCG: Complications of Intravesical Bladder Cancer Treatment
por: To, Uyen, et al.
Publicado: (2014)

Immunological Hallmarks for Clinical Response to BCG in Bladder Cancer
por: Lim, Chun Jye, et al.
Publicado: (2021)

Zebrafish Xenograft: An Evolutionary Experiment in Tumour Biology
por: Wyatt, Rachael A., et al.
Publicado: (2017)

Benefits of Zebrafish Xenograft Models in Cancer Research
por: Chen, Xingyu, et al.
Publicado: (2021)

Modeling Lung Carcinoids with Zebrafish Tumor Xenograft
por: Carra, Silvia, et al.
Publicado: (2022)

Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy
por: KRAJEWSKI, WOJCIECH, et al.
Publicado: (2020)

Vascular graft infections caused by Mycobacterium bovis BCG after BCG immunotherapy for non-muscle-invasive bladder cancer: Case report and review of literature
por: Arsuffi, Stefania, et al.
Publicado: (2023)

Zebrafish xenografts as a fast screening platform for bevacizumab cancer therapy
por: Rebelo de Almeida, Cátia, et al.
Publicado: (2020)

Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
por: Bevers, R F M, et al.
Publicado: (2004)

VEGF signaling mediates bladder neuroplasticity and inflammation in response to BCG
por: Saban, Marcia R, et al.
Publicado: (2011)

Bladder Sparing Therapy for BCG Failures – I – Intravesical Immunotherapy
por: Messing, Edward M.
Publicado: (2017)

Mycobacteria Bovis osteomyelitis following intravesical BCG for bladder cancer
por: Seegobin, Karan, et al.
Publicado: (2017)

Bacillus Calmette-Guérin (BCG) Therapy for Bladder Cancer: An Update
por: Guallar-Garrido, Sandra, et al.
Publicado: (2020)

Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
Publicado: (2021)

Embryonic zebrafish xenograft assay of human cancer metastasis
por: Hill, David, et al.
Publicado: (2018)

The Zebrafish Xenograft Models for Investigating Cancer and Cancer Therapeutics
por: Gamble, John T., et al.
Publicado: (2021)

Targeted therapy of human leukemia xenografts in immunodeficient zebrafish
por: Somasagara, Ranganatha R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1n5b6agu7t9u1051s8abtbki7j